Journals / European Archives of Medical Research / 2018 / Cilt: 34 - Sayı: 4

Evaluation of the Effectiveness of Local Teicoplanin in Diabetic Tibia Plafond Fractures

Pages
217–220
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Although there was no significant difference between the two groups in termsof superficial wound infection, the rates of deep wound infection, reoperation, and LOS in GroupC were significantly higher than those in Group T.Conclusion: Perioperative local TEC administration in diabetic patients who underwent surgeryfor tibial plafond fracture seemed to be effective for deep wound infection, reoperation, and LOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study is to evaluate the effectiveness of local teicoplanin (TEC) administration in diabetic patients who underwent surgery for tibial plafond fracture.Methods: We retrospectively evaluated the records of 22 diabetic patients who underwent osteosynthesis with open reduction plate–screw fixation due to tibial plafond fractures between January2007 and January 2016.
📊
Key Findings & Data:The cases were divided into two groups as teicoplanin group (Group T,n=12) and control group (Group C, n=10) based on perioperative administration of 400 mg TEC.
💡
Conclusion & Impact:Although there was no significant difference between the two groups in termsof superficial wound infection, the rates of deep wound infection, reoperation, and LOS in GroupC were significantly higher than those in Group T.Conclusion: Perioperative local TEC administration in diabetic patients who underwent surgeryfor tibial plafond fracture seemed to be effective for deep wound infection, reoperation, and LOS.
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study is to evaluate the effectiveness of local teicoplanin (TEC) administration in diabetic patients who underwent surgery for tibial plafond fracture.Methods: We retrospectively evaluated the records of 22 diabetic patients who underwent osteosynthesis with open reduction plate–screw fixation due to tibial plafond fractures between January2007 and January 2016. The cases were divided into two groups as teicoplanin group (Group T,n=12) and control group (Group C, n=10) based on perioperative administration of 400 mg TEC. Inaddition to demographic data, both groups were compared for the American Society of Anesthesiologists (ASA) score, duration of operation, length of hospital stay (LOS), post-surgical infection,and rates of reoperation and amputation.Results: There was no significant difference in preoperative demographic data and ASA scores between both groups. Although there was no significant difference between the two groups in termsof superficial wound infection, the rates of deep wound infection, reoperation, and LOS in GroupC were significantly higher than those in Group T.Conclusion: Perioperative local TEC administration in diabetic patients who underwent surgeryfor tibial plafond fracture seemed to be effective for deep wound infection, reoperation, and LOS.

🔖

Cite This Article

KIR, M. Ç. (2022). Evaluation of the Effectiveness of Local Teicoplanin in Diabetic Tibia Plafond Fractures. European Archives of Medical Research, Cilt: 34 - Sayı: 4, 217–220. https://ajindex.com/articles/510473

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Wukich DK, Lowery NJ, McMillen RL, Frykberg RG. Postoperative infection rates in foot and ankle surgery: a comparison of patients with and without diabetes mellitus. J Bone Joint Surg Am 2010
  2. [CrossRef] 2. Thu LT, Dibley MJ, Ewald B, Tien NP, Lam LD. Incidence of surgical site infections and accompanying risk factors in Vietnamese orthopaedic patients. J Hosp Infect 2005
  3. [CrossRef] 3. Bachoura A, Guitton TG, Smith RM, Vrahas MS, Zurakowski D, Ring D. Infirmity and injury complexity are risk factors for surgical-site infection after operative fracture care. Clin Orthop Relat Res 2011
  4. [CrossRef] 4. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004
  5. [CrossRef] 5. Friedman ND, Sexton DJ, Connelly SM, Kaye KS. Risk factors for surgical site infection complicating laminectomy. Infect Control Hosp Epidemiol 2007
  6. [CrossRef] 6. Hikata T, Iwanami A, Hosogane N, Watanabe K, Ishii K, Nakamura M, et al. High preoperative hemoglobin A1c is a risk factor for surgical site infection after posterior thoracic and lumbar spinal instrumentation surgery. J Orthop Sci 2014
  7. [CrossRef] 7. Costigan W, Thordarson DB, Debnath UK. Operative Management of Ankle Fractures in Patients with Diabetes Mellitus. Foot Ankle Int 2007
  8. [CrossRef] 8. White CB, Turner NS, Lee GC, Haidukewych GJ. Open Ankle Fractures in Patients With Diabetes Mellitus. Clin Orthop Relat Res 2003
  9. [CrossRef] 9. De Lada F, Santoro D, Rinaldi E, Suter F, Cruciani M, Guaglianone MH, et al. Teicoplanin in the treatment of infections by staphylococci, clostridium difficile and other gram-positive bacteria. J Antimicrob Chemother 1989
  10. [CrossRef] 10. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1999
  11. [CrossRef] 11. De Lalla F, Viola R, Pellizzer G, Lazzarini L, Tramarin A, Fabris P. Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: An open study. Antimicrob Agents Chemother 2000
  12. [CrossRef] 12. Kline AJ, Gruen GS, Pape HC, Tarkin IS, Irrgang JJ, Wukich DK. Early Complications Following the Ope